Sands Capital Ventures’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.58M | Hold |
481,770
| – | – | 1.1% | 14 |
|
|
2025
Q1 | $4.21M | Hold |
481,770
| – | – | 1.03% | 14 |
|
|
2024
Q4 | $6.92M | Hold |
481,770
| – | – | 1.5% | 13 |
|
|
2024
Q3 | $10.9M | Hold |
481,770
| – | – | 3.06% | 8 |
|
|
2024
Q2 | $9.37M | Hold |
481,770
| – | – | 3.14% | 7 |
|
|
2024
Q1 | $18.1M | Hold |
481,770
| – | – | 4.36% | 6 |
|
|
2023
Q4 | $27M | Hold |
481,770
| – | – | 7.5% | 6 |
|
|
2023
Q3 | $19.9M | Hold |
481,770
| – | – | 5.88% | 7 |
|
|
2023
Q2 | $26.9M | Hold |
481,770
| – | – | 7.96% | 6 |
|
|
2023
Q1 | $26.9M | Hold |
481,770
| – | – | 6.64% | 7 |
|
|
2022
Q4 | $17.6M | Hold |
481,770
| – | – | 4.81% | 10 |
|
|
2022
Q3 | $13.7M | Hold |
481,770
| – | – | 3.99% | 8 |
|
|
2022
Q2 | $21.8M | Buy |
+481,770
| New | +$21.8M | 5.99% | 8 |
|